A 78-year-old woman with major depressive disorder was start… | MyMerci
Medical Emergencies PA
Question

A 78-year-old woman with major depressive disorder was started on escitalopram 10 mg PO daily 2 weeks ago. She reports new headache, nausea, and confusion, and her family says she fell once at home. Today her serum sodium is 124 mEq/L (previously 138). Which action should the nurse take FIRST?

Explanation
SIADH-related hyponatremia is a recognized adverse effect of SSRIs, especially in older adults, women, low body weight, and those on diuretics; it usually appears within 2–4 weeks of starting therapy. Symptoms reflect cerebral edema (headache, nausea, confusion, falls, seizures at very low Na). Priority is to hold the offending drug, notify the prescriber, and implement fluid restriction while monitoring sodium and neurologic status. Adding a thiazide worsens hyponatremia. Doubling the dose increases the risk. Rapid IV NS bolus risks osmotic demyelination and is not first-line; correction should be slow (≤8–10 mEq/L per 24 h).

In-depth explanation

Older adults on a new SSRI presenting with confusion or a fall need immediate sodium check and drug review — not symptom dismissal as "depression" or "aging".

Clinical scenario

Scenario A 78-year-old woman with MDD started escitalopram 10 mg PO daily 2 weeks ago. She now has headache, nausea, confusion, and one witnessed fall. Vital signs: BP 118/68, HR 82, RR 18, T 36.8°C. Labs: Na 124 mEq/L (baseline 138), K 4.1, Cr 0.8, urine osmolality 480 mOsm/kg, serum osmolality 262 mOsm/kg, urine Na 60 mEq/L → consistent with SIADH. No signs of dehydration or volume overload. Home meds: escitalopram, atorvastatin, calcium-vitamin D.

Key concepts

Browse all questions No login required

Master the NCLEX-RN with MyMerci

Thousands of NCLEX-style questions with detailed rationale — in your language. Track your progress and study smarter.

Start for free
Read in another language: English한국어日本語繁體中文Tiếng Việt

For study reference only. Always follow current clinical guidelines and your institution’s protocols.